Pavel Hamet
Fondateur chez Prognomix, Inc.
Profil
Pavel Hamet is the founder of Prognomix, Inc. (founded in 2005) and currently holds the position of President, Co-Chief Executive Officer & Director.
He is also currently a Director at Bellus Health (Innodia), Inc., Canadian Institutes of Health Research, Medpharmgene, Inc., and a Professor at the University of Montréal.
Dr. Hamet previously served as Chairman at Canada Foundation for Innovation, Director at AGC Biologics SpA, Director at BioCapital Investment Advisors, Inc. (from 2003 to 2005), Director at Société de développement Angus, and President at Canadian Hypertension Society.
He obtained a doctorate degree from McGill University in 1972 and another doctorate degree from the University of Charles in 1967.
Postes actifs de Pavel Hamet
| Sociétés | Poste | Début |
|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - |
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Fondateur | 01/01/2005 |
Canadian Institutes of Health Research
 Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Directeur/Membre du Conseil | 02/06/2010 |
| University of Montréal | Corporate Officer/Principal | - |
| Société Francophone Du Diabete | Directeur/Membre du Conseil | 01/01/2010 |
Medpharmgene, Inc.
 Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Directeur/Membre du Conseil | - |
Anciens postes connus de Pavel Hamet
| Sociétés | Poste | Fin |
|---|---|---|
BioCapital Investment Advisors, Inc.
 BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Directeur/Membre du Conseil | 31/12/2005 |
Société de développement Angus
 Société de développement Angus Real Estate DevelopmentFinance Société de développement Angus engages in real estate developments. It specializes in concept development and planning, legal and financial engineering services, acquisition of land and buildings, and marketing, leasing and sales of developed spaces. The company was founded by Christian Yaccarini in 1995 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - |
| Canadian Hypertension Society | President | - |
| ░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Pavel Hamet
| University of Charles | Doctorate Degree |
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Commercial Services |
| Canada Foundation For Innovation | Miscellaneous |
| Canadian Hypertension Society | |
| Société Francophone Du Diabete | |
Société de développement Angus
Société de développement Angus Real Estate DevelopmentFinance Société de développement Angus engages in real estate developments. It specializes in concept development and planning, legal and financial engineering services, acquisition of land and buildings, and marketing, leasing and sales of developed spaces. The company was founded by Christian Yaccarini in 1995 and is headquartered in Montreal, Canada. | Finance |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Commercial Services |